Home / Inspections / 1298596

FDA Inspection 1298596 — GlaxoSmithKline LLC

GlaxoSmithKline LLC — FEI 1033964

The FDA completed an inspection of GlaxoSmithKline LLC on February 20, 2026 in Zebulon, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zebulon, NC (United States)

Facility

Other inspections at this facility

  • 1229588 (VAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043270 (NAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987392 (VAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940149 (NAI Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 841675 (NAI Fri May 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources